Table 3.
Typing method | Total (n = 242) | 2a (n = 90) | 4a/Y (n = 107)c | ||||||
---|---|---|---|---|---|---|---|---|---|
No. types | DI | CI | No. types | DI | CI | No. types | DI | CI | |
PFGE | 95 | 0.908 | 0.8778-0.9385 | 44 | 0.9421 | 0.9100-0.9742 | 19 | 0.5733 | 0.4681-0.6785 |
MLVA4b | 82 | 0.9149 | 0.8879-0.9418 | 48 | 0.9745 | 0.9643-0.9847 | 14 | 0.6438 | 0.5503-0.7373 |
MLVA8c | 90 | 0.9163 | 0.8891-0.9434 | 51 | 0.9778 | 0.9682-0.9874 | NA | NA | NA |
MLVA36 | 104 | 0.927 | 0.9008-0.9539 | 54 | 0.9800 | 0.9708-0.9893 | 14 | 0.6438 | 0.5503-0.7373 |
aIncluding an isolate with Y serotype, which was a single-locus variant of the predominant MLVA type of subserotype 4a.
bFor the total: SF3, SF4, SF6, SF7; for 2a group: SF3, SF4, SF6, SF7; for 4a group: SF2, SF3, SF17, SF22
cFor the total: SF3, SF4, SF6, SF7, SF8, SF9, SF10, SF25; 2a group: SF3, SF4, SF6, SF7, SF8, SF9, SF11, SF27